These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6097425)

  • 1. Comparative pharmacokinetics of four new cephalosporins: moxalactam, cefotaxime, cefoperazone and ceftazidime in neonates.
    Bégué P; Safran C; Quiniou F; Lasfargues G; Quinet B
    Dev Pharmacol Ther; 1984; 7 Suppl 1():105-8. PubMed ID: 6097425
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium.
    Charles D; Larsen B
    Antimicrob Agents Chemother; 1986 May; 29(5):873-6. PubMed ID: 3729345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
    McNamee W; Drusano GL; Tatem BA; Standiford HC
    J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
    Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of first, second and third generation cephalosporins.
    Forsgren A
    Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
    Lüthy R; Blaser J; Bonetti A; Simmen H; Wise R; Siegenthaler W
    Rev Infect Dis; 1982; 4 Suppl():S581-4. PubMed ID: 6296966
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
    Barriere SL; Ozasa DC; Mordenti J
    Antimicrob Agents Chemother; 1985 Jul; 28(1):55-7. PubMed ID: 3929680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
    Lüthy R; Blaser J; Bonetti A; Simmen H; Wise R; Siegenthaler W
    Antimicrob Agents Chemother; 1981 Nov; 20(5):567-75. PubMed ID: 6275776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
    Wise R; Andrews JM
    Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential value of cefoperazone in bacterial meningitis: experimental studies.
    Durack DT; Perfect JR
    Drugs; 1981; 22 Suppl 1():60-4. PubMed ID: 6269824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
    Noble JT; Barza M
    Drugs; 1985 Sep; 30(3):175-81. PubMed ID: 3899596
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
    Perfect JR; Durack DT
    J Antimicrob Chemother; 1981 Jul; 8(1):49-58. PubMed ID: 6265429
    [No Abstract]   [Full Text] [Related]  

  • 16. Penetration and clearance of cefoperazone and moxalactam in pleural fluid.
    Yamada H; Iwanaga T; Nakanishi H; Yamaguchi M; Iida K
    Antimicrob Agents Chemother; 1985 Jan; 27(1):93-5. PubMed ID: 3985598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA; LeFrock JL; Vercler MJ
    Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary pharmacokinetic study of ceftazidime in premature, new born and small infants.
    Prinsloo JG; Delport SD; Moncrieff J; Paton AM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():361-4. PubMed ID: 6352645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.